118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects

BMC Medical Genetics

Volumn 10, Issue , 2009, Pages

  Shaw, Gary M ^a,d,e   Lu, Wei ^b   Zhu, Huiping ^b   Yang, Wei ^c   Briggs, Farren B S ^d   Carmichael, Suzan L ^c,e   Barcellos, Lisa F ^d   Lammer, Edward J ^e   Finnell, Richard H ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c March of Dimes   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETAINE HOMOCYSTEINE METHYLTRANSFERASE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE 2; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1; METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ARTICLE; CONGENITAL HEART MALFORMATION; CONOTRUNCAL HEART DEFECT; CONTROLLED STUDY; ETHNICITY; FOLATE METABOLISM; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPINA BIFIDA; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; RISK; RISK FACTOR; SPINAL DYSRAPHISM; TRANSPORT AT THE CELLULAR LEVEL; UNITED STATES;

BIOLOGICAL TRANSPORT; CALIFORNIA; CASE-CONTROL STUDIES; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SPINAL DYSRAPHISM;

EID: 67649209221     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-10-49     Document Type: Article

References (61)

1. Prevention of neural tube defects: Results of the Medical Research Council vitamin study. MRC Vitamin Study Research Group Lancet 1991, 338(8760):131-7 10.1016/0140-6736(91)90133-A 1677062
2. Czeizel AE Dudάs I Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation N Engl J Med 1992, 327(26):1832-5 1307234
3. Shaw GM Lammer EJ Wasserman CR O'Malley CD Tolarova MM Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally Lancet 1995, 346:393-6 10.1016/ S0140-6736(95)92778-6 7623568
4. Shaw GM O'Malley CD Wasserman CR Tolarova MM Lammer EJ Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring Am J Med Genet 1995, 59:536-45 10.1002/ajmg.1320590428 8585581
5. Botto LD Mulinare J Erickson JD Occurrence of congenital heart defects in relation to maternal multivitamin use Am J Epidemiol 2000, 151(9):878-84 10791560
6. Czeizel AE Tüth M Rockenbauer M Population-based case-control study of folic acid supplementation during pregnancy Teratology 1996, 53(6):345-51 10.1002/ (SICI)1096-9926(199606)53:6<345::AID-TERA5>3.0.CO;2-Z 8910980
7. Werler MM Hayes C Louik C Shapiro S Mitchell AA Multivitamin supplementation and risk of birth defects Am J Epidemiol 1999, 150(7):675-82 10512421
8. Loffredo LC Souza JM Freitas JA Mossey PA Oral clefts and vitamin supplementation Cleft Palate Craniofac J 2001, 38(1):76-83 10.1597/ 1545-1569(2001)038<0076:OCAVS>2.0.CO;2 11204686
9. Itikala PR Watkins ML Mulinare J Moore CA Liu Y Maternal multivitamin use and orofacial clefts in offspring Teratology 2001, 63(2):79-86 10.1002/1096-9926(200102)63:2<79::AID-TERA1013>3.0.CO;2-3 11241430
10. Czeizel AE Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation Am J Med Genet 1996, 62(2):179-83 10.1002/ (SICI)1096-8628(19960315)62:2<179::AID-AJMG12>3.0.CO;2-L 8882400
11. Czeizel AE Dobó M Vargha P Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities Birth Defects Res A Clin Mol Teratol 2004, 70(11):853-61 10.1002/bdra.20086 15523663
12. Put van der NM Steegers-Theunissen RP Frosst P Trijbels FJ Eskes TK Heuvel van den LP Mariman EC den Heyer M Rozen R Blom HJ Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida Lancet 1995, 346(8982):1070-1 10.1016/S0140-6736(95)91743-8 7564788
13. Put van der NM Heuvel van den LP Steegers-Theunissen RP Trijbels FJ Eskes TK Mariman EC den Heyer M Blom HJ Decreased methylene tetrahydrofolate reductase activity due to the 677C - >T mutation in families with spina bifida offspring J Mol Med 1996, 74(11):691-4 10.1007/s001090050073 8956155
14. Kirke PN Mills JL Whitehead AS Molloy A Scott JM Methylenetetrahydrofolate reductase mutation and neural tube defects Lancet 1996, 348(9033):1037-8 10.1016/S0140-6736(05)64971-9 8855891
15. Shaw GM Rozen R Finnell RH Wasserman CR Lammer EJ Maternal vitamin use, genetic variations of infant methylene tetrahydrofolate reductase and risk for spina bifida Am J Epidemiol 1998, 148(1):30-7 9663401
16. Posey DL Khoury MJ Mulinare J Admas MJ Jr Ou CY Is mutated MTHFR a risk factor for neural tube defects? Lancet 1996, 347(9002):686-7 10.1016/ S0140-6736(96)91236-2 8596396
17. Botto LD Yang Q 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review Am J Epidemiol 2000, 151(9):862-77 10791559
18. Junker R Kotthoff S Vielhaber H Halimeh S Kosch A Koch HG Kassenböhmer R Heineking B Nowak-Göttl U Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease Cardiovas Res 2001, 51(2):251-4 10.1016/ S0008-6363(01)00286-3
19. Wenstrom KD Johanning GL Johnston KE DuBard M Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations Am J Obstet Gynecol 2001, 184(5):806-17 10.1067/mob.2001.113845 11303187
20. Croen LA Shaw GM Jensvold NJ Harris JA Birth defects monitoring in California: A resource for epidemiological research Paediatr Perinat Epidemiol 1991, 5(4):423-7 10.1111/j.1365-3016.1991.tb00728.x 1754501
21. Schulman J Hahn JA Quality control of birth defects registry data: A case study Publ Health Rep 1993, 108(1):91-8
22. Lovmar L Syvänen AC Multiple displacement amplification to create a long-lasting source of DNA for genetic studies Hum Mutat 2006, 27(1):603-14 10.1002/humu.20341 16786504
23. Holbrook JF Stabley D Sol-Church K Exploring whole genome amplification as a DNA recovery tool for molecular genetic studies J Biomol Tech 2005, 16(2):125-33 2291715 16030319
24. Bergen AW Qi Y Haque KA Welch RA Chanock SJ Effects of DNA mass on multiple displacement whole genome amplification and genotyping performance BMC Biotechnol 200,5(5):24 1249558 16168060 10.1186/ 1472-6750-5-24
25. Fredicksen A Meyer K Ueland PM Vollset SE Grotmol T Schneede J Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism Human Mut 2007, 28(9):856-65 10.1002/humu.20522
26. Piedrahita JA Oetma B Bennett GD van Waes J Kamen BA Richardson J Lacey SW Anderson RG Finnell RH Mice lacking the folic-acid binding protein Folbp1 are defective in early embryonic development Nat Genet 1999, 23(2):228-32 10.1038/13861 10508523
27. Linden van der IJ Afman LA Heil SG Blom HJ Genetic variation in genes of folate metabolism and neural-tube defect risk Proc Nutr Soc 2006, 65(2):204-15 16672082
28. Boyles AL Billups AV Deak KL Siegel DG Mehltretter L Slifer SH Bassuk AG Kessler JA Reed MC Nijhout HF George TM Enterline DS Gilbert JR Speer MC NTD Collaborative Group Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions Environ Health Perspect 2006, 114(10):1547-52 1626421 17035141
29. Hobbs CA James SJ Parsian A Krakowiak PA Jerrigan S Greenhaw JJ Lu Y Cleves MA Congenital heart defects and genetic variants in the methylenetetrahydrofolate reductase gene J Med Genet 2006, 43(2):162-6 2564637 15951337 10.1136/jmg.2005.032656
30. Shaw GM Iovannisci DM Yang W Finnell RH Carmichael SL Cheng S Lammer EJ Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes Am J Med Genet A 2005, 138(1):21-6 16100725
31. Storti S Vittorini S Lascone MR Sacchelli M Collavoli A Ripoli A Cocchi G Biagini A Clerico A Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects Clin Chem Lab Med 2003, 41(3):276-80 10.1515/CCLM.2003.043 12705333
32. Deng L Elmore CL Lawrance AK Matthews RG Rozen R Methionine synthase reductase deficiency results in adverse reproductive outcomes and congenital heart defects in mice Mol Genet Metab 2008, 94(3):336-42 10.1016/j.ymgme.2008.03.004 18413293
33. Zhu H Wicker NJ Shaw GM Lammer EJ Hendricks K Suarez L Canfield M Finnell RH Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects Mol Genet Metab 2003, 78(3):216-21 10.1016/ S1096-7192(03)00008-8 12649067
34. Doolin MT Barbaux S McDonnell M Hoess K Whitehead AS Mitchell LE Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida Am J Hum Genet 2002, 71(5):1222-6 385102 12375236 10.1086/344209
35. Guçant-Rodriguez RM Rendeli C Namour B Venuti L Romano A Anello G Bosco P Debard R Gçrard P Viola M Salvaggio E Guçant JL Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans Neurosci Lett 2003, 344(3):189-92 10.1016/S0304-3940(03)00468-3 12812837
36. De Marco P Calevo MG Moroni A Arata L Merello E Finnell RH Zhu H Andreussi L Cama A Capra V Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population J Hum Genet 2002, 47(6):319-24 10.1007/s100380200043 12111380
37. O'Leary VB Mills JL Pangilinan F Kirke PN Cox C Conley M Weiler A Peng K Shane B Scott JM Parle-McDermott A Molly AM Brody LC Members of the Birth Defects Research Group Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association Mol Genet Metab 2005, 85(3):220-7 10.1016/j.ymgme.2005.02.003 15979034
38. Banerjee R Zou CG Redox regulation and reaction mechanism of human cystathionine-B-synthase: A PLP-dependent hemesensor protein Arch Biochem Biophys 2005, 433(1):144-56 10.1016/j.abb.2004.08.037 15581573
39. Wilson A Platt R Wu Q Leclerc D Christensen B Yang H Gravel RA Rozen R A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida Mol Genet Metab 1999, 67(4):317-23 10.1006/mgme.1999.2879 10444342
40. Candito M Rivet R Herbeth B Boisson C Rudigoz RC Luton D Journel H Oury JF Rouv F Saura R Vernhet I Gaucherand P Muller F Guidicelli B Heckenroth H Poulain P Blayau M Francannet C Roszy KL Brustiç C Staccini P Gçrard P Fillion-Emery N Guçant-Rodriguez RM Van Obberghen E Guçant JL Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: A multicenter case-control study Am J Med Genet Part A 2008, 146A(9):1128-33 10.1002/ajmg.a.32199
41. Relton CL Wilding CS Laffling AJ Jonas PA Burgess T Binks K Tawn EJ Burn J Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy Mol Genet Metabol 2004, 81(4):273-81 10.1016/ j.ymgme.2003.12.010
42. van Beynum IM Kouwenberg M Kapusta L den Heijer M Linden van der IJ Daniels O Blom HJ MTRR 66A>G polymorphism in relation to congenital heart defects Clin Chem Lab Med 2006, 44(11):1317-23 10.1515/ CCLM.2006.254 17087642
43. Verkleij-Hagoort AC van Driel LM Lindemans J Isaacs A Steegers EA Helbing WA Uitterlinden AG Steegers-Theunissen RP Genetic lifestyle factors related to the periconception vitamin B12 status and congenital heart defects: A Dutch case-control study Mol Genet Metab 2008, 94(1):112-9 10.1016/j.ymgme.2007.12.002 18226574
44. Parle-McDermott A Kirke PN Mills JL Molloy AM Cox C O'Leary VB Pangilinan F Conley M Cleary L Brody LC Scott JM Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population Eur J Hum Genet 2006, 14(6):768-72 10.1038/sj.ejhg.5201603 16552426
45. De Marco P Merello E Calevo MG Mascelli S Raso A Cama A Capra V Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958>A polymorphism for neural tube defect risk J Hum Genet 2006, 51(2):98-103 10.1007/s10038-005-0329-6 16315005
46. Johnson WG Stenroos ES Spychala JR Chatkupt S Ming SX Buyske S New 19 bp deletion polymorphism in Intron-1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet A 2004, 124A(4):339-45 10.1002/ajmg.a.20505 14735580
47. Parle-McDermott A Pangilinan F Mills JL Kirke PN Gibney ER Troendle J O'Leary VB Molloy AM Conley M Scott JM Brody LC The 19-bp deletion polymorphism in Intron-1 of dihyrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population Am J Med Genet A 2007, 143A(11):1174-80 10.1002/ajmg.a.31725 17486595
48. Linden van der IJ Nguyen U Heil SG Franke B Vloet S Gellekink H den Heijer M Blom HJ Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida Mol Genet Met 2007, 91(1):98-103 10.1016/j.ymgme.2007.01.009
49. Shaw GM Lammer EJ Zhu H Baker MW Neri E Finnell RH Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida Am J Med Genet 2002, 108(1):1-6 10.1002/ajmg.10195 11857541
50. Shaw GM Zhu H Lamer EJ Yang W Finnell RH Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects Am J Epidemiol 2003, 158(8):747-52 10.1093/aje/kwg189 14561664
51. Pei L Zhu H Ren A Li Z Hao L Finnell RH Li Z Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population Birth Defects Res A Clin Mol Teratol 2005, 73(6):430-3 10.1002/bdra.20130 15799025
52. Pei L Zhu H Zhu J Ren A Finnell RH Li Z Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial defects and congenital heart defects in China Ann Epidemiol 2006, 16(5):352-6 10.1016/j.annepidem.2005.02.014 16019224
53. De Marco P Calevo MG Moroni A Merello E Raso A Finnell RH Zhu H Andreussi L Cama A Capra V Reduced folate carrier polymorphism (80A->G) and neural tube defects Eur J Hum Genet 2003, 11(3):245-52 10.1038/sj.ejhg.5200946 12673279
54. Trinh BN Ong CN Coetzee GA Yu MC Laird PW Thymidylate synthase: A novel genetic determinant of plasma homocysteine and folate levels Hum Genet 2002, 111(3):299-302 10.1007/s00439-002-0779-2 12215845
55. Wilding CS Relton CL Sutton MJ Jonas PA Lynch SA Tawn EJ Burn J Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the Northern United Kingdom Birth Def Res A Clin Mol Teratol 2004, 70(7):483-5 10.1002/bdra.20038
56. Volcik KA Shaw GM Zhu H Lammer EJ Laurent C Finnell RH Associations between polymorphisms within the thymidylate synthase gene and spina bifida Birth Defects Res A Clin Mol Teratol 2003, 67(11):924-8 10.1002/ bdra.10029 14745930
57. Liu J Schmitz JC Lin X Tai N Yan W Farrell M Bailly M Chen T Chu E Thymidylate synthase as a translational regulator of cellular gene expression Biochim Biophys Acta 2002, 1587(2-3):174-82 12084459
58. Kawate H Landis DM Loeb LA Distribution of mutations in human thymidylate synthase yielding resistance to 5-fluorodeoxyuridine J Biol Chem 2002, 277(39):36304-11 10.1074/jbc.M204956200 12147691
59. Ulrich CM Bigler J Bostick R Fosdick L Potter JD Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas Cancer Res 2002, 62(12):3361-4 1206797
60. Thomas DC Witte JS PoAnt: Population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 2002, 11(6):505-12 12050090
61. Wacholder S Rothman N Caporaso N Counterpoint: Bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer Cancer Epidemiol Biomarkers Prev 2002, 11(6):513-20 12050091